AstraZeneca PLC
Get $10 bonus on your first $100 deposit for ZEG.DE
Get $10 bonus on your first $100 deposit for ZEG.DE
AstraZeneca PLC (ZEG.DE) Stock Competitors & Peer Comparison
See (ZEG.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ZEG.DE | €160.70 | +0.59% | 249.2B | 28.49 | €5.64 | +1.69% |
| LLY.DE | €796.00 | -0.45% | 752.1B | 40.47 | €19.67 | +0.68% |
| JNJ.DE | €201.65 | -1.20% | 485.7B | 21.38 | €9.43 | +2.21% |
| 4AB.DE | €174.15 | -2.71% | 308B | 86.21 | €2.02 | +3.28% |
| 6MK.DE | €102.08 | -1.66% | 252.4B | 16.36 | €6.24 | +2.78% |
| AMG.DE | €296.85 | -1.13% | 160B | 24.29 | €12.22 | +2.78% |
| GIS.DE | €117.26 | -2.02% | 145.5B | 20.22 | €5.80 | +2.34% |
| PFE.F | €22.93 | -0.43% | 130.7B | 19.81 | €1.16 | +6.40% |
| PFE.DE | €22.93 | -0.43% | 130.4B | 19.76 | €1.16 | +6.40% |
| BRM.DE | €49.41 | -1.18% | 100.6B | 16.69 | €2.96 | +4.34% |
Stock Comparison
ZEG.DE vs LLY.DE Comparison April 2026
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 249.2B. In comparison, LLY.DE has a market cap of 752.1B. Regarding current trading prices, ZEG.DE is priced at €160.70, while LLY.DE trades at €796.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.49, whereas LLY.DE's P/E ratio is 40.47. In terms of profitability, ZEG.DE's ROE is +0.23%, compared to LLY.DE's ROE of +0.98%. Regarding short-term risk, ZEG.DE is more volatile compared to LLY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.Check LLY.DE's competition here
ZEG.DE vs JNJ.DE Comparison April 2026
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 249.2B. In comparison, JNJ.DE has a market cap of 485.7B. Regarding current trading prices, ZEG.DE is priced at €160.70, while JNJ.DE trades at €201.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.49, whereas JNJ.DE's P/E ratio is 21.38. In terms of profitability, ZEG.DE's ROE is +0.23%, compared to JNJ.DE's ROE of +0.34%. Regarding short-term risk, ZEG.DE is more volatile compared to JNJ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.Check JNJ.DE's competition here
ZEG.DE vs 4AB.DE Comparison April 2026
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 249.2B. In comparison, 4AB.DE has a market cap of 308B. Regarding current trading prices, ZEG.DE is priced at €160.70, while 4AB.DE trades at €174.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.49, whereas 4AB.DE's P/E ratio is 86.21. In terms of profitability, ZEG.DE's ROE is +0.23%, compared to 4AB.DE's ROE of -3.62%. Regarding short-term risk, ZEG.DE is less volatile compared to 4AB.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.Check 4AB.DE's competition here
ZEG.DE vs 6MK.DE Comparison April 2026
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 249.2B. In comparison, 6MK.DE has a market cap of 252.4B. Regarding current trading prices, ZEG.DE is priced at €160.70, while 6MK.DE trades at €102.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.49, whereas 6MK.DE's P/E ratio is 16.36. In terms of profitability, ZEG.DE's ROE is +0.23%, compared to 6MK.DE's ROE of +0.36%. Regarding short-term risk, ZEG.DE is more volatile compared to 6MK.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.Check 6MK.DE's competition here
ZEG.DE vs AMG.DE Comparison April 2026
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 249.2B. In comparison, AMG.DE has a market cap of 160B. Regarding current trading prices, ZEG.DE is priced at €160.70, while AMG.DE trades at €296.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.49, whereas AMG.DE's P/E ratio is 24.29. In terms of profitability, ZEG.DE's ROE is +0.23%, compared to AMG.DE's ROE of +0.97%. Regarding short-term risk, ZEG.DE is more volatile compared to AMG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.Check AMG.DE's competition here
ZEG.DE vs GIS.DE Comparison April 2026
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 249.2B. In comparison, GIS.DE has a market cap of 145.5B. Regarding current trading prices, ZEG.DE is priced at €160.70, while GIS.DE trades at €117.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.49, whereas GIS.DE's P/E ratio is 20.22. In terms of profitability, ZEG.DE's ROE is +0.23%, compared to GIS.DE's ROE of +0.41%. Regarding short-term risk, ZEG.DE is more volatile compared to GIS.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.Check GIS.DE's competition here
ZEG.DE vs PFE.F Comparison April 2026
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 249.2B. In comparison, PFE.F has a market cap of 130.7B. Regarding current trading prices, ZEG.DE is priced at €160.70, while PFE.F trades at €22.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.49, whereas PFE.F's P/E ratio is 19.81. In terms of profitability, ZEG.DE's ROE is +0.23%, compared to PFE.F's ROE of +0.09%. Regarding short-term risk, ZEG.DE is more volatile compared to PFE.F. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.Check PFE.F's competition here
ZEG.DE vs PFE.DE Comparison April 2026
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 249.2B. In comparison, PFE.DE has a market cap of 130.4B. Regarding current trading prices, ZEG.DE is priced at €160.70, while PFE.DE trades at €22.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.49, whereas PFE.DE's P/E ratio is 19.76. In terms of profitability, ZEG.DE's ROE is +0.23%, compared to PFE.DE's ROE of +0.09%. Regarding short-term risk, ZEG.DE is more volatile compared to PFE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.Check PFE.DE's competition here
ZEG.DE vs BRM.DE Comparison April 2026
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 249.2B. In comparison, BRM.DE has a market cap of 100.6B. Regarding current trading prices, ZEG.DE is priced at €160.70, while BRM.DE trades at €49.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.49, whereas BRM.DE's P/E ratio is 16.69. In terms of profitability, ZEG.DE's ROE is +0.23%, compared to BRM.DE's ROE of +0.39%. Regarding short-term risk, ZEG.DE is more volatile compared to BRM.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.Check BRM.DE's competition here
ZEG.DE vs SNW.DE Comparison April 2026
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 249.2B. In comparison, SNW.DE has a market cap of 95.7B. Regarding current trading prices, ZEG.DE is priced at €160.70, while SNW.DE trades at €79.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.49, whereas SNW.DE's P/E ratio is 19.74. In terms of profitability, ZEG.DE's ROE is +0.23%, compared to SNW.DE's ROE of +0.15%. Regarding short-term risk, ZEG.DE is more volatile compared to SNW.DE. This indicates potentially higher risk in terms of short-term price fluctuations for ZEG.DE.Check SNW.DE's competition here
ZEG.DE vs BAYN.SG Comparison April 2026
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 249.2B. In comparison, BAYN.SG has a market cap of 40.2B. Regarding current trading prices, ZEG.DE is priced at €160.70, while BAYN.SG trades at €40.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.49, whereas BAYN.SG's P/E ratio is N/A. In terms of profitability, ZEG.DE's ROE is +0.23%, compared to BAYN.SG's ROE of -0.12%. Regarding short-term risk, ZEG.DE is less volatile compared to BAYN.SG. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.Check BAYN.SG's competition here
ZEG.DE vs BAYN.DE Comparison April 2026
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 249.2B. In comparison, BAYN.DE has a market cap of 40.1B. Regarding current trading prices, ZEG.DE is priced at €160.70, while BAYN.DE trades at €40.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.49, whereas BAYN.DE's P/E ratio is -11.08. In terms of profitability, ZEG.DE's ROE is +0.23%, compared to BAYN.DE's ROE of -0.12%. Regarding short-term risk, ZEG.DE is less volatile compared to BAYN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.Check BAYN.DE's competition here
ZEG.DE vs IDP.DE Comparison April 2026
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 249.2B. In comparison, IDP.DE has a market cap of 21.7B. Regarding current trading prices, ZEG.DE is priced at €160.70, while IDP.DE trades at €148.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.49, whereas IDP.DE's P/E ratio is 19.69. In terms of profitability, ZEG.DE's ROE is +0.23%, compared to IDP.DE's ROE of +0.07%. Regarding short-term risk, ZEG.DE is less volatile compared to IDP.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.Check IDP.DE's competition here
ZEG.DE vs GS7.DE Comparison April 2026
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 249.2B. In comparison, GS7.DE has a market cap of 0. Regarding current trading prices, ZEG.DE is priced at €160.70, while GS7.DE trades at €20.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 28.49, whereas GS7.DE's P/E ratio is 17.31. In terms of profitability, ZEG.DE's ROE is +0.23%, compared to GS7.DE's ROE of +0.34%. Regarding short-term risk, ZEG.DE is less volatile compared to GS7.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.Check GS7.DE's competition here